Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03830177 · ClinicalTrials.gov registry record · Phase 1

Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult

A Phase 1 study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Completed
Registry status
Phase 1
Development phase
77
Enrollment target

NCT03830177 is a Phase 1 study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 77 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03830177, a Phase 1 study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

COMPLETED
Registry status
Phase 1
Development phase
77 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the safety and efficacy of a novel topical treatment for dry scalp conditions, including dandruff, seborrheic dermatitis, and atopic dermatitis. The study investigates clinical improvements in symptom severity, participant experience with the treatment, and changes in the scalp microbiome before and after use. By studying this treatment, the investigators aim to provide children and adults with a natural, effective option for managing dry scalp conditions.

Interventions

  • DRUG Natural Treatment

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2019-07-08
Est. Completion 2023-10-04
Phase Phase 1

What the Registry Record Tells You About NCT03830177

The ClinicalTrials.gov registry entry for NCT03830177 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Natural Treatment is the first listed.

NCT03830177 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03830177 about?

NCT03830177 is a clinical study titled "Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult". The purpose of this study is to evaluate the safety and efficacy of a novel topical treatment for dry scalp conditions, including dandruff, seborrheic dermatitis, and atopic dermatitis. The study investigates clinical improvements in symptom severity, participant experience with the treatment, and c...

What is the current status of trial NCT03830177?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 77 participants. The study started on 2019-07-08. Estimated completion is 2023-10-04.

What interventions are being tested in trial NCT03830177?

The interventions under investigation include: Natural Treatment (DRUG).

Who is sponsoring clinical trial NCT03830177?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.